Joseph P. AllenSpecial to Valley NewsFor nearly two years, progressive activists have lobbied the Biden administration to weaken international patent protections on COVID treatments. The political pressure was immense. And at several points, it seemed like some officials were ready to cave.But fortunately for American innovation — and patients worldwide — the Biden administration recently rejected these requests. At the World Trade Organization meeting that recently wrapped up in Abu Dhabi, the U.S. delegation refused to lend its support to the proposal, effectively killing it for now.Let's hope this decision serves as a template for other pending issues that could deal a body blow to our economic development and the well-being of our citizens. The future of America's i
